Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease

Clinical trial NCT01541579 · COMPLETED

Trial details

NCT number: NCT01541579
Sponsor: Tigenix S.A.U.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2012-07-01
Primary completion: 2015-07-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.